Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
60.49
+1.94 (3.31%)
At close: Jun 26, 2026, 4:00 PM EDT
60.37
-0.12 (-0.20%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Veracyte Employees
Veracyte had 755 employees as of December 31, 2025. The number of employees decreased by 69 or -8.37% compared to the previous year.
Employees
755
Change (1Y)
-69
Growth (1Y)
-8.37%
Revenue / Employee
$717,540
Profits / Employee
$116,574
Market Cap
4.83B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Charles River Laboratories International | 19,700 |
| Revvity | 11,000 |
| RadNet | 9,276 |
| Qiagen | 5,700 |
| Sotera Health Company | 3,000 |
| NeoGenomics | 2,500 |
| GeneDx Holdings | 1,300 |
| Twist Bioscience | 979 |
VCYT News
- 17 days ago - Veracyte Transcript: AGM 2026 - Transcripts
- 24 days ago - Veracyte Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 25 days ago - Veracyte Transcript: 46th Annual William Blair Growth Stock Conference - Transcripts
- 25 days ago - Veracyte Slides: 46th Annual William Blair Growth Stock Conference - Filings
- 26 days ago - Veracyte assumed with an Outperform at Wolfe Research - TheFly
- 27 days ago - Veracyte Transcript: Study update - Transcripts
- 27 days ago - Veracyte Slides: Study update - Filings
- 27 days ago - Veracyte announces U.S. commercial launch of Prosigna ROR test - TheFly